Colgate-Palmolive as a consumer staples anchor

Colgate-Palmolive (CL) has drawn investor attention after recent trading left the shares at $85.14, with short term returns mixed and longer term performance varying across the past year and past 3 months.

Beyond the share price, the company sits firmly in the global consumer staples space, with oral care, personal and home care, and pet nutrition products sold through traditional retailers, eCommerce channels, dentists, veterinarians and other professionals.

The current share price of $85.14 sits against a mixed backdrop, with a 1 month share price return of a 9% decline, contrasting with a 3 month gain of 10.67% and a 3 year total shareholder return of 20.79%, suggesting momentum has softened recently after longer term compounding.

If Colgate-Palmolive has you thinking about where else steady consumer demand and cash flows might matter, it can be worth widening your search with 20 top founder-led companies

With Colgate-Palmolive combining mixed recent returns, annual revenue of US$20,382m and net income of US$2,132m, the key question is whether the current US$85.14 share price leaves upside or if markets already price in future growth.

Most Popular Narrative: 12.5% Undervalued

Colgate-Palmolive's most followed narrative places fair value at $97.26 versus the last close of $85.14, framing the current price as meaningfully below that estimate.

Expansion and premiumization of core oral care lines like Colgate Total, coupled with the roll out of complementary products across 75 markets, are set to capture increased value from emerging middle class consumers and rising health/hygiene awareness globally, which supports the potential for top line organic sales acceleration and improved pricing power.

Behind that fair value is a detailed set of assumptions about how fast sales might compound, how much margins could widen, and what earnings multiple the market might accept. The narrative connects those building blocks into a single view on where the stock could reasonably trade if those inputs occur.

Result: Fair Value of $97.26 (UNDERVALUED)

However, this depends on consumer caution easing and on input costs such as palm oil not putting renewed pressure on margins and volume growth.

Another View: What the P/E Ratio Is Saying

That 12.5% gap to fair value sits against a very different message from Colgate-Palmolive's P/E ratio. At 32x earnings, the stock trades well above peers at 21.6x, the global household products average at 17.1x, and a fair ratio of 23.6x. This implies valuation risk rather than a clear bargain, so how much premium are you comfortable paying for this brand strength?

Next Steps

With the signals so mixed, the real question is how this balance of concern and optimism sits with you. Take a moment to review the underlying data and sentiment, then weigh up the 3 key rewards and 3 important warning signs

Looking for more investment ideas?

If this story has you thinking more broadly about your portfolio, now is a good time to scan the wider market for fresh opportunities that fit your style.

• Spot potential mispricing by reviewing companies that appear cheap on quality and fundamentals using the 58 high quality undervalued stocks.
• Strengthen your income stream by focusing on companies offering solid yields and resilient payouts through the 13 dividend fortresses.
• Prioritise resilience by filtering for companies with robust finances and lower risk profiles using the 68 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.